Drug Profile
Desmopressin oral - Unigene Laboratories
Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Unigene Laboratories
- Class Antidiuretics; Antihaemorrhagics; Hormones; Peptides; Urologics; Vasoconstrictors; Vasopressins
- Mechanism of Action Hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Diabetes insipidus; Enuresis; Haematological disorders
Most Recent Events
- 04 Apr 2008 Preclinical trials in Diabetes insipidus in USA (PO)
- 04 Apr 2008 Preclinical trials in Enuresis in USA (PO)
- 04 Apr 2008 Preclinical trials in Haematological disorders in USA (PO)